As continuous intravenous insulin therapy is generally necessary and potentially serious complications can appear during therapeutic management (hypokalemia, hypoglycemia, pulmonary edema, cerebral edema), close clinical and paraclinical monitoring is indispensable. This evidence concerns the gene INS and Hypoglycemia.